This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| NELSEN ROBERT | 4,637,137 | 11,000 |
| Arch Venture Fund VII LP | 4,242,051 | 0 |
| Flynn James E Through Deerfield Private Design Fund III, L.P. | 1,466,654 | 0 |
| AKKARAJU SRINIVAS | 1,274,616 | 17,500 |
| AKKARAJU SRINIVAS see footnote 1 | 1,059,938 | 0 |
| Flagship Ventures Fund IV, L.P. | 918,664 | 0 |
| AISLING CAPITAL III LP | 908,565 | 0 |
| Simonian Nancy A | 692,723 | 0 |
| Flynn James E Through Deerfield Special Situations Fund, L.P. | 628,566 | 0 |
| Young Richard A | 321,711 | 17,500 |
| Olson Eric R | 59,734 | 0 |
| Roth David | 59,719 | 0 |
| Redmile Group, LLC | 49,793 | 0 |
| Polaris Management Co. VII, L.L.C. | 48,320 | 0 |
| Nashat Amir | 48,320 | 17,500 |
| Springhorn Jeremy P. | 35,000 | 94,000 |
| Stephens Kristin | 30,885 | 0 |
| Alles Mark J | 10,000 | 17,500 |
| Perspecta Trust LLC Owned by the JEB Syros Trust, of which Perspecta Trust LLC is trustee. | 0 | 0 |
| WuXi PharmTech Healthcare Fund I L.P. | 0 | 0 |
| Simonian Nancy A By the Douglas and Nancy Cole Family Trust f/b/o William H. Cole | 0 | 0 |
| KANIA EDWIN M JR | 0 | 0 |
| NELSEN ROBERT Shares held by ARCH Venture Fund VII, L.P. | 0 | 0 |
| SHARP PHILIP A | 0 | 17,500 |
| Dunsire Deborah | 0 | 35,000 |
| AKKARAJU SRINIVAS By Samsara BioCapital, L.P. | 0 | 0 |
| Kuvalanka Kyle D. | 0 | 78,000 |
| Bancel Stephane | 0 | 22,000 |
| WuXi Healthcare Ventures II, L.P. | 0 | 0 |
| Simonian Nancy A By the Douglas and Nancy Cole Family Trust f/b/o Bennett H. Cole | 0 | 0 |
| Haas Jason | 0 | 80,000 |
| DeSimone Colleen Elizabeth | 0 | 13,016 |
| Eckhardt Sue Gail | 0 | 17,500 |
| Shaw Alice Tsang | 0 | 22,000 |
| SATO VICKI L | 0 | 11,000 |
| 0 | 0 | |
| WIRTH PETER | 0 | 17,500 |
| Ferra Joseph J Jr | 0 | 119,000 |
| AFEYAN NOUBAR | 0 | 0 |
| Patel Sanj K | 0 | 11,000 |
| Fanucci Marsha | 0 | 17,500 |
| Gray Nathanael | 0 | 0 |
| BYBEE CLINTON | 0 | 0 |
| Chee Conley | 0 | 80,000 |
| Quirk Gerald E | 0 | 94,000 |
| JEB Syros Trust | 0 | 0 |
| BONNEY MICHAEL W | 0 | 11,000 |
| AKKARAJU SRINIVAS by Samsara BioCapital, L.P. | 0 | 0 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|